EP2840920A1 - Sandale ayant des séparateurs d'orteils - Google Patents
Sandale ayant des séparateurs d'orteilsInfo
- Publication number
- EP2840920A1 EP2840920A1 EP13781454.7A EP13781454A EP2840920A1 EP 2840920 A1 EP2840920 A1 EP 2840920A1 EP 13781454 A EP13781454 A EP 13781454A EP 2840920 A1 EP2840920 A1 EP 2840920A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- toe
- footwear
- article
- toes
- separator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003371 toe Anatomy 0.000 claims abstract description 147
- 239000004744 fabric Substances 0.000 claims abstract description 39
- 239000000463 material Substances 0.000 claims abstract description 38
- 210000002683 foot Anatomy 0.000 claims abstract description 36
- 229920000079 Memory foam Polymers 0.000 claims abstract description 29
- 239000008210 memory foam Substances 0.000 claims abstract description 29
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 18
- 238000000926 separation method Methods 0.000 claims abstract description 17
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 14
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 14
- 239000004599 antimicrobial Substances 0.000 claims abstract description 14
- 230000035807 sensation Effects 0.000 claims abstract description 8
- 229940121375 antifungal agent Drugs 0.000 claims abstract description 7
- 210000001255 hallux Anatomy 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 6
- 239000006260 foam Substances 0.000 claims description 6
- 230000000813 microbial effect Effects 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000003351 stiffener Substances 0.000 claims description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 abstract description 3
- 201000004647 tinea pedis Diseases 0.000 abstract description 3
- 239000004753 textile Substances 0.000 description 6
- 241000233866 Fungi Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229920001875 Ebonite Polymers 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000011496 polyurethane foam Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 206010006585 Bunion Diseases 0.000 description 1
- 101100394497 Caenorhabditis elegans toe-1 gene Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920000657 LRPu Polymers 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 208000000491 Tendinopathy Diseases 0.000 description 1
- 206010043255 Tendonitis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/26—Footwear with health or hygienic arrangements with foot-supporting parts with toe-spacers or toe-spreaders
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B3/00—Footwear characterised by the shape or the use
- A43B3/10—Low shoes, e.g. comprising only a front strap; Slippers
- A43B3/101—Slippers, e.g. flip-flops or thong sandals
- A43B3/102—Slippers, e.g. flip-flops or thong sandals leaving the heel of the foot bare
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B3/00—Footwear characterised by the shape or the use
- A43B3/10—Low shoes, e.g. comprising only a front strap; Slippers
- A43B3/101—Slippers, e.g. flip-flops or thong sandals
- A43B3/102—Slippers, e.g. flip-flops or thong sandals leaving the heel of the foot bare
- A43B3/103—Slippers, e.g. flip-flops or thong sandals leaving the heel of the foot bare characterised by the attachment of the toestrap
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B3/00—Footwear characterised by the shape or the use
- A43B3/12—Sandals; Strap guides thereon
Definitions
- This invention relates to sandals with toe separators and particularly to sandals with multiple toe separators.
- a new category of footwear has been developed, based on the venerable "flip-flop” sandal design. These sandals have additional toe separation elements in addition to the flip- flop strap worn between a big toe and a first adjacent toe. Because of the tendency of adjacent toes to naturally be close to each other, if not if not actually touching, insertion of physical separators therebetween can provide a measure of discomfort not normally associated with "flip-flop" sandals having a single separator between a big toe and an adjacent toe where spacing therebetween is more pronounced and discomfort is minimized.
- any common sandal having a toe separator with the toe separation and slipper wearing holding being effected between a relatively hard rubber or plastic between the toes and bearing against the foot at the base of the toes.
- the toe separation element in the common flip-flop sandal is unitary with and of a one piece construction of the upper holding strap. The hard nature of the strap for structural holding is thus carried through with the portion thereof, which effects the toe separation and pressing against the foot at the base of the toes with significant discomfort or irritation.
- the area between the toes is subject to retention of moisture and fungus and bacteria build up resulting in conditions such as athlete's foot with the condition with increased irritation being exacerbated as a result of the toe separation of the flip flop type of slippers or sandals.
- the present invention comprises an article of footwear comprising a base sole element and an upper element configured to enclose a human foot therebetween, wherein at least one toe separator element extends between the base sole element and the upper element.
- Each of the at least one toe separator is configured and positioned to provide a wedging separation between adjacent toes of the human foot. and configured to provide a cushioning sensation to the adjacent toes in contact therewith.
- Another aspect of the present invention is an article of footwear comprising a base sole element and an upper element configured to enclose a human foot therebetween.
- At least one toe separator element extends between the base sole element and the upper element, with each of the at least one toe separator being configured and positioned to provide a wedging separation between adjacent toes of the human foot and is comprised of at least one of an antimicrobial, antibacterial and antifungal material with the at least one toes separator being configured to provide respective antimicrobial, antibacterial and antifungal activity treatment to an area between the adjacent toes with which the toe separator is in contact.
- the invention further comprises a method for preventing microbial, bacterial and fungal growth between toes of a human foot, comprising the steps of:
- the present invention comprises sandals, defined herein as footwear having at least one toe separator element (preferably one or four toe separators) configured for placement between adjacent foot toes, the at least one toe separator extending between an upper footwear element and a bottom base or sole wherein the toe separator element or elements, particularly between the small toes, are comprised of a material which provides an external soft or cushioned sensation to the toes of a wearer.
- toe separator element preferably one or four toe separators
- the soft or cushioned material is configured to provide a compressive reaction or "give” to lateral forces exerted by the adjacent toes and foot at the base of the toes with reduced or minimal pressure or binding such as exerted with hard rubber, hard plastic and even fabrics alone (which would be susceptible to a cutting sensation) or fabrics on a relatively hard support.
- the toe separator elements are elements separate from and of different compositions than the compositions of the uppers (usually straps in sandals) and soles or bases of the sandals, which, for structural integrity in use, are usually made of harder materials.
- These separator elements are integrated with the uppers and soles such as by being sewn or anchored therewith or by other attachment expedients.
- the cushioning compositions of the toe separators be able to resist wear and degradation, as a result of cushioning compressions, and that they are wearably reusable, i.e., effectively maintain their structural configuration with continued wearing use.
- cushioning elements included foam, memory foam, air filled tubes, gels, etc.
- a highly preferred material, for use as a cushioned toe separator or separators is the material commonly known as "memory foam” or gel, which is able to provide cushioning comfort and retains such comfort and aesthetic appearance with a “memory” resilience to substantially an original dimension, even with continued wearing and use.
- the memory foam or gel is encased in a material tube such as (lycra, jersey,etc) backed with the memory foam material.
- central hard cores may be utilized to provide structural integrity for the separators but with the separators being configured to minimize or eliminate any external hard sensations by such hard cores
- Memory foam is polyurethane with additional chemicals increasing its viscosity and density. It is often referred to as "visco-elastic" polyurethane foam, or low-resilience polyurethane foam. Higher-density memory foam softens in reaction to body heat, allowing it to mold to a warm body in a few minutes. A lower density memory foam is pressure-sensitive and molds quickly to the shape of a body pressing against it, returning to its original shape once the pressure is removed.
- memory foam examples include synthetic memory sponge of man-made cellulose dervid from sodium sulphate as well as a variety of other materials.
- Memory foam separators as utilized in the present invention between the toes have been found to provide meaningful separation in a comfortable way to give the benefits of toe separation, such as better circulation in the feet; which often provides added benefits for people with circulation problems, diabetics, etc. Better balance is also provided, by allowing for a broader foundation. In addition, a body is better able to respond to subtle shifts in weight and react appropriately and a better grip can be had while walking.
- the toe separators can also keep toes separated sufficiently and comfortably for healing after foot surgery, as needed. Additional benefits include helping keep toes flexible, which improves gait especially with toes used to wearing shoes that keep toes stiff which can cause knee problems, tendinitis, and bunion formation.
- the toe separators also help regain a more natural line in feet and helps redistribute weight to the outside edges of feet, as opposed to middle of feet. This better distribution of weight contributes to healthy alignment.
- the thickness of the memory foam is between 2 and 5mm and is more preferably about 3 or 4mm.
- the width of the material preferably used in forming the toe tube separator is about 28-35mm (in an initial sheet form) with a preferred average width of about 30mm.
- the memory foam is provided or produced as an integral backing for a decorative fabric material.
- a planar element of appropriate size with he fabric and foam backing is folded and stitched to provide the respective toe separator elements.
- the tube is of circular, elliptical, or oval cross section, without edges, though other cross sectional configurations are possible, with the compression or cushioning minimizing the effect of any edges of the foam material.
- the formed tube is provided with a reinforcement or stiffening material core, such as a thin rubber core rod therewithin of typically about 2mm in width.
- the stitching is preferably positioned between 2-5mm from the edge in order to minimize toe irritation.
- This tubing is then used as toe separators for sandals or shoes.
- the toe separators can also be made from encapsulated gel or silicone or latex.
- stitching seams are positioned, with connection to the sandal, away from contact with adjacent toes to minimize irritation and facing toward the foot at the base of the toes, for aesthetic appearance.
- the memory foam and surface material as well as core reinforcement materials are preferably all slightly stretchable to provide a degree of give for the wearer's toes. Modifications in this regard of degree of stretchability are a function of different styles
- seam irritation may be further minimized by skiving or tapering the ends before formation of the tube.
- the memory foam can be seamlessly extruded with a fully enclosing fabric cover, without a seam.
- the present invention further comprises the use of an enclosing fabric or any other fabric used in toe separation of anti-fungal and anti-bacterial and therapeutic materials within or on the fabric.
- an enclosing fabric or any other fabric used in toe separation of anti-fungal and anti-bacterial and therapeutic materials within or on the fabric This can benefit the between toes areas subject to "athlete's foot” and can serves to prevent deterioration of fabrics used in the toe separator material subject to fungus and bacterial growth in a moist area between the toes. These fabrics are well known and are commonly used in hospital bedding and patient gowns. Examples of sources for the fabrics or antimicrobials for use in fabrics include X-STATIC® fabrics, Silvadur® antimicrobials from the Dow Corporation and antimicrobials for fabrics from Belton Industries.
- Antimicrobial textile products increase the comfort and hygiene factor making them more pleasant to wear with odors being neutralized and skin problems, caused by microbial growth reduced. Comfort in sandals as well as overall well being is enhanced by the direct application of antimicrobials in the toe separators to areas subject to fungus and microbial growth.
- Microbes fall into three categories; bacteria, fungi and algae, although only the first two are generally applicable to textiles or to skin. Bacteria and fungi can cause
- Antimicrobial treatments can be added in a number of ways including as a coating to the finished fabric or fiber or by incorporating the antimicrobial agent within the fiber during the spinning process, as in the manufacturing of polyester and nylon.
- Antimicrobial agents used to treat textiles fall into two categories, known as “static” and “cidalff and the table below outlines the main differences. Many traditional treatments fall into the “cidal” category and because of their leaching action need to be evaluated for their health and environmental effects. New development tends to favor the "Static” type agents as these are of lower risk.
- Antimicrobial fabrics can deter microbial growth in one of two ways. Either "passively”, by inhibiting the growth of micro-organisms through inherent surface structure without the use of agents - linen for example displays such characteristics, as well as lambs wool, or “actively”, using antimicrobial agents to either kill or inhibit the growth of any microbes present such as in treated cotton/denim fabrics.
- the fabric surface used in the toe separators may have bumps or other texture irregularities to stimulate blood flow in between the toes and effect a massaging function for additional comfort and foot care.
- the toe separators may include vibrating coils to effect a similar or massaging function
- the actual positioning of the toe separation tubular elements may also determine a greater or lesser degree of comfort because of the physiology or anatomical configurationof a typical foot.
- many sandals with multiple toe separators have such separators arrange regularly in a straight, albeit angle line.
- the toe separator between the big toe and the first digit is preferably offset from the straight line to either be horizontal (relative to the long axis of the sandal) with respect to the next toe separator or with the latter being slightly forward of the big toe separator.
- Figure 1 is a bottom view of a typical human left foot
- Figure 2 is a left foot sandal with toe separators of the present invention adapted for use with the foot of Figure 1 ;
- Figure 3 is a corresponding right foot sandal with the first toe separator having been cut to show the cross section of the toe separator;
- Figure 4A is a top perspective view of a composite fabric-memory foam from which the toe separators of the sandals of Figures 2-3 are sized and formed, showing the fabric layer;
- Figure 4B is a bottom view of the composite fabric-memory foam of Figure 4, showing the memory foam layer;
- Figure 5 depicts a manufactured sheet of six sections of the material with memory foam backing, each of which is separated to make the individual toe separators;
- Figure 6 depicts a toe separator material prior to rolling formation, together with a centrally placed stiffener element
- Figure 7A and 7B respectively depict a stitched toe separator element rolled into a seamed tube with straight cut ends and the separator material prior to rolling and stitching;
- Figures 7C and 7D respectively depict a section of separator material with skived ends and the rolled seamed tube formed therefrom;
- Figures 8A-C depict various textured surfaces for use as the fabric in the toe separators with massaging functions.
- a typical human foot 10 is shown in Figure 1 with toes 1-5 (big toe to pinky) and the respective spacings la-4a therebetween.
- the sandal 20 in Figure 2 is conformed to be worn by the foot 10 with spacings 21a, 22a and 23 a being conformed to contain toes 2-4 respective lyand with big toe 1 and pinky 5 being positioned exterior to toe separator elements 21 and 25 respectively.
- Toe separator elements 21-24 are affixed to upper strap element 26 and sole 25 to hold them together but are not initially integral with elements 25 and 26 and are comprised of different materials.
- the toe separator elements 21-24 are shown as being stitched to upper strap element 26.
- the toe separator elements 21-24 are positioned to respectively separate toes 1 and 2, toes 2 and 3, toes 3 and 4, and toes 4 and 5. Relative positioning of the toe separators 22-24 is generally along diagonal line D-D with toe separator 21 being out of line D-D and below toe separator 22, in conformity with the anatomical configuration of the human foot 10 shown in Figure 1 and the between toe spacings thereof.
- a first toe separator 21 ' is shown as severed from the sole 25' of sandal 20' to show the cross section 30 of the toe separator.
- the cross sectioned toe separator 21 ' has a fabric exterior 32 enclosing and covering memory foam 31 with a stitched section 33 facing the inside of the sandal.
- Figures 4A and 4B depict both sides of the sheet 15 used to form the toe separators 21-24 with fabric layer 16 configured to face the outside when the sheet is rolled and the toe separator is formed and with the memory foam layer 17 forming the central core element.
- Figure 5 depicts a manufactured fabric-foam layer sheet 45 preformed with severable elements 45a-f for the cutting to size and rolling of six toe separator elements.
- Figure 6 depicts the sheet 15 with an optional then rubber, rigidizing central element 50 for rolling in the formation of the separator elements to provide structural rigidity as required.
- Figures 7 A and 7B depict the sheet 15 rolled into toe separator 100 with seamed fold 101, without the ends 15a and 15b having been skived.
- Figures 7C and 7D depict the sheet 15 with skived ends 15c and 15d with formation of toe separator 200.
- the seamed fold 201 is of lesser volume and area extent as compared to seamed fold 101 and accordingly provides additional comfort enhancement.
- Figures 8 A, 8B and 8C depict alternative textured surfaces 61, 71 and 81 of outer facing fabric layers 60, 70 and 80 to provide a massaging effect to the toes in contact therewith.
- antimicrobials may be added to any or all of the fabric layers or to any fabric or similar outer layers of toe separators in order to enhance comfort and well being of a wear of sandals with toe separation.
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261639410P | 2012-04-27 | 2012-04-27 | |
US13/870,452 US20130333243A1 (en) | 2012-04-27 | 2013-04-25 | Sandal with toe separators |
PCT/US2013/038338 WO2013163501A1 (fr) | 2012-04-27 | 2013-04-26 | Sandale ayant des séparateurs d'orteils |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2840920A1 true EP2840920A1 (fr) | 2015-03-04 |
EP2840920A4 EP2840920A4 (fr) | 2016-04-27 |
EP2840920B1 EP2840920B1 (fr) | 2020-12-02 |
Family
ID=49483913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13781454.7A Active EP2840920B1 (fr) | 2012-04-27 | 2013-04-26 | Sandale ayant des séparateurs d'orteils |
Country Status (3)
Country | Link |
---|---|
US (2) | US20130333243A1 (fr) |
EP (1) | EP2840920B1 (fr) |
WO (1) | WO2013163501A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130333243A1 (en) * | 2012-04-27 | 2013-12-19 | Wellrox, LLC | Sandal with toe separators |
US9320313B2 (en) | 2013-02-20 | 2016-04-26 | Nike, Inc. | Split-sole footwear |
US10757996B2 (en) | 2015-09-22 | 2020-09-01 | Totes Isotoner Corporation | Footwear having memory foam |
CN105559158A (zh) * | 2016-03-06 | 2016-05-11 | 海宁汉德袜业有限公司 | 防干裂保健袜 |
WO2019050528A1 (fr) * | 2017-09-08 | 2019-03-14 | Diana Laird | Chaussure avec fixation sur deux orteils |
US20190321209A1 (en) * | 2018-04-20 | 2019-10-24 | Angela A. Hatzis | Peditrack |
WO2019207569A1 (fr) * | 2018-04-22 | 2019-10-31 | Insand Ltd. | Semelle intérieure, insert, semelle, ainsi que chaussures et article chaussant comportant de tels composants |
USD913653S1 (en) | 2019-04-12 | 2021-03-23 | Critts, LLC | Shoe |
USD914336S1 (en) | 2019-04-12 | 2021-03-30 | Critts, LLC | Shoe |
USD950204S1 (en) | 2019-04-12 | 2022-05-03 | Critts, LLC | Shoe |
US11696617B2 (en) | 2019-04-12 | 2023-07-11 | Critts, LLC | Footwear with toe bar |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2506308A (en) * | 1947-07-31 | 1950-05-02 | Maynier Stella | Toe separating device |
US2511101A (en) * | 1948-11-01 | 1950-06-13 | Clarke Maurice Wright | Chiropodial device |
US2740207A (en) * | 1952-02-21 | 1956-04-03 | Med I Peds Inc | Medicated shoes |
US2758395A (en) * | 1953-08-13 | 1956-08-14 | Miyaji Seiichi | Rubber sandal |
US2751693A (en) * | 1955-01-25 | 1956-06-26 | Delia V Baker | Toe spacing sandal |
US2808662A (en) * | 1955-03-08 | 1957-10-08 | Helen E Webb | Toe spacing scuffs or sandals |
US2947095A (en) * | 1957-09-09 | 1960-08-02 | Miyachi Kiyoichi | Sandal |
US2928191A (en) * | 1958-08-01 | 1960-03-15 | Meltzer Jack | Shoe provided with toe thong |
US3928927A (en) * | 1974-11-25 | 1975-12-30 | Dwight Collin Brown | Sandals and method for making same |
US4017987A (en) * | 1976-01-28 | 1977-04-19 | Perez Jr Louis A | Pedicure sandal |
US4051610A (en) * | 1976-05-04 | 1977-10-04 | Yoshihiro Shigeji | Sandal |
JPH032266Y2 (fr) * | 1987-09-21 | 1991-01-22 | ||
US6151801A (en) * | 1998-10-16 | 2000-11-28 | Frederiksen; Ben G. | Sandal |
US6508016B1 (en) * | 2000-10-17 | 2003-01-21 | R & S Trading Company, Inc. | Water-resistant and floatable footwear and method of manufacture therefor |
US20020121030A1 (en) * | 2001-03-02 | 2002-09-05 | Christina Coleman | Thong footwear cushion |
US6678971B2 (en) * | 2002-02-04 | 2004-01-20 | Marian J. Brooks | Pedicure sandal |
US8002675B2 (en) * | 2003-10-17 | 2011-08-23 | Fenf, Llc | Foot-therapy and toe-aligning device |
US7131939B2 (en) * | 2003-10-17 | 2006-11-07 | Frederic Ferri | Toe stretcher |
US20050150132A1 (en) * | 2004-01-14 | 2005-07-14 | Gail Iannacone | Footwear with expanded thermoplastic beads in the footbed |
US20060026862A1 (en) * | 2004-08-05 | 2006-02-09 | Bcny International | Article of footwear and associated of manufacture |
US7681332B2 (en) * | 2005-07-12 | 2010-03-23 | Kathy Allen | Post pedicure shoe |
US20070163048A1 (en) * | 2005-09-19 | 2007-07-19 | Kimball Helen R | Method and device for pressure offloading |
US20080000107A1 (en) * | 2006-07-01 | 2008-01-03 | Christi Ann Styles | Footwear having interchangeable decorative straps and strips |
US7694436B2 (en) * | 2006-10-13 | 2010-04-13 | Scott Mullen | Footwear repair |
US7603797B2 (en) * | 2006-10-16 | 2009-10-20 | Chu-Yun Chung | Portable shoe |
BRPI0604324A (pt) * | 2006-10-20 | 2008-06-10 | Sonia Regina Saad Whitaker | meio de fixação de tiras em solado de calçados do tipo chinelos ou sandálias |
EP1920669A1 (fr) * | 2006-11-07 | 2008-05-14 | JOHNSON & JOHNSON GmbH | Protection pour sangle de maintien des orteils et chaussure avec une telle protection |
US20080222915A1 (en) * | 2007-03-12 | 2008-09-18 | David Carwile Viar | Footwear and Method of Manufacturing Same |
US20090038181A1 (en) * | 2007-08-09 | 2009-02-12 | Deirdre Loughnane | Footwear with detachable straps |
FR2920645A1 (fr) * | 2007-09-11 | 2009-03-13 | Frederic Jean Jerome Dat | Chaussure |
US8832971B2 (en) * | 2007-11-05 | 2014-09-16 | Chele Suzanne Heid | Therapeutic footwear |
US8082683B1 (en) * | 2007-11-28 | 2011-12-27 | Munch Mikako A | Strap wrap |
US7980005B1 (en) * | 2008-02-22 | 2011-07-19 | Young Joyce C | Toe jammers |
US8151491B2 (en) * | 2008-04-03 | 2012-04-10 | Nike, Inc. | Reversible article of footwear |
US20090320325A1 (en) * | 2008-06-25 | 2009-12-31 | Antonio Escario | Thong sandal with protective covering |
US8943712B2 (en) * | 2008-07-22 | 2015-02-03 | Nancy M. Buck | Removable attachment for footwear |
US8117768B2 (en) * | 2008-07-24 | 2012-02-21 | Advanced Manufacturing Group, Ltd. | Anatomical footwear toepiece and method of manufacturing the same |
US20100024247A1 (en) * | 2008-08-04 | 2010-02-04 | Feeney Daniel T | Protective appliance for flip-flop type footwear |
US20100115793A1 (en) * | 2008-11-13 | 2010-05-13 | Alissa Kraisosky | Compactable pedicure and evening footwear |
US20110277345A1 (en) * | 2008-12-24 | 2011-11-17 | Arieta Pereira Luiz | Sandal suitable for post-pedicure use |
US20100251569A1 (en) * | 2009-04-06 | 2010-10-07 | Gina Stern | Sandal with toe separators |
US8806781B2 (en) * | 2009-08-11 | 2014-08-19 | Hasmig Sabounjian | Device for wearing thong-type sandals |
US8448351B2 (en) * | 2009-10-29 | 2013-05-28 | Nike, Inc. | Article of footwear with straps |
US20110314692A1 (en) * | 2010-06-28 | 2011-12-29 | Eli Marmar | Open-toe footwear base member system |
US8402675B2 (en) * | 2010-08-24 | 2013-03-26 | Wolverine World Wide, Inc. | Footwear construction and related method of manufacture |
US20120152267A1 (en) * | 2010-12-20 | 2012-06-21 | Youn Jung Chang | Pedicure Slipper with Toe Separator and Method |
US20120204441A1 (en) * | 2011-02-15 | 2012-08-16 | Eleanor Ruth Conner | Sandal and strap assembly |
US20120304499A1 (en) * | 2011-06-02 | 2012-12-06 | Kiesel Laura E | Transferable, Independently Attachable, Self Supporting Footwear Wrap For Stylish Decoration |
AU2012321040B2 (en) * | 2011-10-07 | 2015-04-16 | The 2026 Company Pte Ltd | Open styled footwear and components therefor |
US10098415B2 (en) * | 2012-03-22 | 2018-10-16 | Hari Mari, Llc | Footwear with enhanced toe post |
US20130333243A1 (en) * | 2012-04-27 | 2013-12-19 | Wellrox, LLC | Sandal with toe separators |
-
2013
- 2013-04-25 US US13/870,452 patent/US20130333243A1/en not_active Abandoned
- 2013-04-26 WO PCT/US2013/038338 patent/WO2013163501A1/fr active Application Filing
- 2013-04-26 EP EP13781454.7A patent/EP2840920B1/fr active Active
-
2018
- 2018-09-23 US US16/139,054 patent/US20190116923A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2840920A4 (fr) | 2016-04-27 |
US20190116923A1 (en) | 2019-04-25 |
EP2840920B1 (fr) | 2020-12-02 |
US20130333243A1 (en) | 2013-12-19 |
WO2013163501A1 (fr) | 2013-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2840920B1 (fr) | Sandale ayant des séparateurs d'orteils | |
EP3001991A1 (fr) | Chaussette de soins de santé | |
US20140082971A1 (en) | Footwear with magnets systems | |
US20200205483A1 (en) | Sock orthotic | |
US20110214315A1 (en) | Therapy shoe | |
AU2012321040A1 (en) | Open styled footwear and components therefor | |
CN205456471U (zh) | 具有气垫、磁疗、负离子和远红外按摩的多功能鞋 | |
WO2011109725A2 (fr) | Chaussure thérapeutique | |
US20150208758A1 (en) | Foot Support Shoe Insert | |
JP2009011822A (ja) | 多層靴敷き | |
KR100975909B1 (ko) | 성형틀 및 성형틀을 이용하여 맞춤 깔창을 제조하는 방법 | |
WO2017215084A1 (fr) | Semelle intérieure multifonctionnelle pour soins de santé | |
CN2472519Y (zh) | 袜子 | |
CN215501557U (zh) | 一种复合内里双密度大底女跟鞋 | |
US20150335099A1 (en) | Memory sneaker | |
CN216723344U (zh) | 一种具有抗菌防臭功能的鞋子 | |
US12011062B2 (en) | Orthopedic foot insert | |
CN209594852U (zh) | 一种健步鞋 | |
CN106983229A (zh) | 一种具有换气功能的呼吸鞋垫 | |
CN219628936U (zh) | 一种有防水效果的防水鞋结构 | |
CN215303396U (zh) | 一种透气女跟鞋脚床及女跟鞋 | |
CN218852067U (zh) | 一种鞋子减震部件 | |
KR101187053B1 (ko) | 신발 깔창 | |
CN213920062U (zh) | 一种微孔聚氨酯鞋垫 | |
CN201256661Y (zh) | 一种穴位按摩鞋 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20141125 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602013074471 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A43B0003120000 Ipc: A43B0007260000 |
|
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20160324 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A43B 7/26 20060101AFI20160318BHEP Ipc: A43B 3/12 20060101ALI20160318BHEP Ipc: A43B 3/10 20060101ALI20160318BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20190208 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200402 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1339924 Country of ref document: AT Kind code of ref document: T Effective date: 20201215 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013074471 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210302 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210303 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20201202 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1339924 Country of ref document: AT Kind code of ref document: T Effective date: 20201202 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210302 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210405 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013074471 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210402 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 |
|
26N | No opposition filed |
Effective date: 20210903 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210426 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210402 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201202 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240429 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240429 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240425 Year of fee payment: 12 |